Total n = 610 | Early remission n = 387 | Arm 1 n = 83 | Arm 2 n = 78 | P value arm 1 vs 2 | OOP n = 50 | |
---|---|---|---|---|---|---|
DAS, mean ± SD | 1.5 ± 0.8 | 1.3 ± 0.8 | 2.0 ± 0.7 | 1.9 ± 0.9 | 0.45 | 1.9 ± 0.7 |
HAQ, mean ± SD | 0.5 ± 0.6 | 0.4 ± 0.5 | 0.9 ± 0.7 | 0.8 ± 0.7 | 0.55 | 0.8 ± 0.7 |
Swollen joint count, median (IQR) | 0 (0–1) | 0 (0–1) | 1 (0–2) | 0 (0–2) | 0.25 | 0 (0–2) |
Tender joint count, median (IQR) | 1 (0–3) | 0 (0–2) | 3 (2–5) | 3 (1–6) | 0.84 | 2 (1–4) |
ESR mm/h, median (IQR) | 9 (5–17) | 8 (4–16) | 11 (6–20) | 9 (6–17) | 0.19 | 14 (7–25) |
VAS global health (mm), mean ± SD | 22 ± 22 | 18 ± 21 | 30 ± 21 | 28 ± 24 | 0.61 | 32 ± 22 |
Total SHS, median (IQR) | 0 (0–0.5) | 0 (0–0.5) | 0 (0–1.1) | 0 (0–0) | 0.12 | 0 (0–0.3) |
Erosive, n (%) | 50 (8) | 39 (10) | 2 (2) | 8 (10) | 0.04 | 1 (2) |
SHS progression, n (%) | 50 (8) | 33 (9) | 9 (11) | 5 (6) | 0.31 | 3 (6) |
DAS-remission, n (%) | 301 (49) | 241 (62) | 22 (27) | 24 (31) | 0.76 | 14 (28) |
Drug-free remission, n (%) | 131 (22) | 111 (29) | 6 (7) | 7 (9) | 0.73 | 7 (14) |
ACR/EULAR remission, n (%) | 138 (23) | 117 (30) | 2 (2) | 14 (18) | 0.001 | 5 (10) |